Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Bovine Viral Diarrhea Virus Envelope Glycoprotein E2 (BVDV gp55), C-Fc

Cat. No.VG3F75

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Bovine Viral Diarrhea Virus Envelope Glycoprotein E2 (BVDV gp55), C-Fc is a recombinant protein expressed from Mammalian Expression System. Its predicted molecular weight is 52.8 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System Mammalian Expression System
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 52.8 kDa
Physical State Lyophilized
Formulation PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

E2 (gp55) is the most immunodominant structural protein of BVDV and the primary target for neutralizing antibodies. As a Type I transmembrane protein, it forms heterodimers with E1 to facilitate viral attachment to host cell receptors, such as CD154. E2 is highly polymorphic, driving the antigenic diversity between BVDV-1 and BVDV-2 strains. Due to its essential role in cell entry and the induction of protective immunity, E2 is the cornerstone antigen for recombinant subunit vaccines and diagnostic screening assays.

Protein Bovine Viral Diarrhea Virus Envelope Glycoprotein E2 (BVDV gp55)
Protein Synonym gp55; BVDV E2; Major envelope glycoprotein; Viral protein gp55; Pestivirus E2
UniProt ID L7RZU1

Shipping and Storage

This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket